Report : Asia Pacific Frozen Tissues Samples Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Frozen Normal Tissue Samples, Frozen Tumor Tissue Samples, and Frozen Diseased Tissue Samples), Application (Disease Diagnosis & Treatment, Cancer & Other Diseases Research, and Morphological Analysis), and End User (Academic & Research Institutes, Hospitals & Clinics, Diagnostic Centers, and Others)
Cancer and Other Diseases Research Segment to Dominate APAC Frozen Tissues Samples Market during 2020–2028
According to a new market research study on “APAC Frozen Tissues Samples Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Application, and End User” is expected to reach US$ 23.73 million by 2028 from 9.13 US$ million in 2021. The market is estimated to grow at a CAGR of 14.6% from 2021 to 2028. The report provides trends prevailing in the APAC frozen tissues samples market along with the drivers and restraints pertaining to the market growth. Rapid growth of biotechnology industry in developing regions is the major factor driving the growth of the APAC frozen tissues samples market. However, risk associated with preservation and maintenance of frozen tissues samples hinders the growth of APAC frozen tissues samples market.
The APAC frozen tissues samples market is segmented on the basis of product type, application, end user, and country. The market, based on product, is segmented into frozen normal tissues samples, frozen tumor tissues samples, and frozen diseased tissue samples. The frozen tissue tumor samples segment held the largest share of the market in 2021. Based on application, the APAC frozen tissues samples market is segmented into disease diagnosis and treatment, cancer and other diseases research, and morphological analysis. In 2021, the cancer and other diseases research segment accounted for the largest share of the market. The APAC frozen tissues samples market, by end user, is segmented into academic and research institutes, hospitals and clinics, diagnostic centers, and others. In 2021, the academic and research institutes segment held the largest market share. Based on country, the APAC frozen tissues samples market is segmented into the Australia, China, India, Japan, South Korea, and Rest of APAC.
AMS Biotechnology Ltd.; Audubon Bioscience Co; Bay Biosciences LLC; BioChain Institute Inc.; OriGene Technologies, Inc.; ProteoGenex, Inc.; REPROCELL Inc.; and ZenBio, Inc. are among the leading companies in the APAC frozen tissues samples market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: firstname.lastname@example.org